Market-Moving News for March 28th
Market-Moving News for March 28th
3月28日市場動向新聞
AVTX: 406% | Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
AVTX：406% | Avalo 收購抗 IL-1β MAB 並宣佈高達 1.85 億美元的私募融資
XLO: 399% | Xilio Therapeutics shares are trading higher after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing.
XLO：399％ | Xilio Therapeutics宣佈與吉利德科學簽訂腫瘤激活的 IL-12 計劃的獨家許可協議後，該公司股價走高。該公司宣佈了1130萬澳元的私募股權融資。
BDRX: 46% | Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers
BDRX：46% | Biodexa 的 MTX110 有望延長對抗侵襲性腦癌的預期壽命